VRDN
Viridian Therapeutics Inc
18.70$
+1.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.1% | -3.3% | -2.1% | -8,985.2% | – | -4.9% | -3.4% | -2.7% | +9.1% | +0.8% | -3.3% | – | |
| – | +91.4% | -51.3% | -7.3% | -25.9% | +2.9% | +13.9% | +6.1% | +3.7% | +6.6% | +11.7% | +26.8% | – | |
| – | – | -188.3% | – | -155.4% | – | -3,112.0% | – | -480.3% | – | -126.3% | – | – | |
| – | -88.1% | -100.0% | – | +181.7% | -61.1% | -24.6% | -51.2% | +202.4% | +89.0% | -90.4% | +5,578.3% | – | |
| – | -453.3% | -15.7% | – | -236.6% | -25.7% | – | -24.3% | +66.5% | -369.2% | – | -399.2% | – | |
| – | – | +36.9% | – | – | – | – | – | +99.6% | -200.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,187.1% | -11.0% | -99.9% | +226,773.1% | -85.5% | -74.1% | -91.7% | +1,321.1% | +3,638.7% | -98.4% | +5,014.4% | – | |
| – | -135.8% | – | – | +478.1% | -208.7% | – | -93.3% | +4,618.0% | -18.3% | -184.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.